FDAFDA · Food and drugs·Recall number D-841-2013
Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30
Published August 14, 2013 · Recall initiated: March 7, 2013
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent drug: low fill volume in some of the capsules
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Sanofi US
- Distributor
- Nationwide
- Lot
- Lot # 3097657, Exp 3/15
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.